Profile
Brian McGuinness is currently the Head of New Product and Business Opportunities at Crescendo Biologics Ltd. He previously worked as an Evaluation Manager in Business Development at MedImmune Ltd. and as an Associate Consultant at Apex Healthcare, Inc. He also held positions as a Principal at IP2IPO Innovations Ltd., AstraZeneca UK Ltd., BerGenBio ASA, and as a Technology Consultant at Heptares Therapeutics Ltd. Additionally, he worked as a Consultant at Algeta ASA and as an Associate Consultant at Alacrita LLP.
Dr. McGuinness holds a doctorate degree from The University of Southampton, an undergraduate degree from the University of Bristol, and an MBA from The Open University.
Brian McGuinness active positions
| Companies | Position | Start |
|---|---|---|
Crescendo Biologics Ltd.
Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the development of new medicines based on antibody fragment technology | Corporate Officer/Principal | - |
Former positions of Brian McGuinness
| Companies | Position | End |
|---|---|---|
IP2IPO Innovations Ltd.
IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business development and technology transfer services | Corporate Officer/Principal | - |
Apex Healthcare, Inc.
Apex Healthcare, Inc. Internet Software/ServicesTechnology Services Provides web based managed care technology and administrative service solutions | Corporate Officer/Principal | - |
| ONCOINVENT ASA | Corporate Officer/Principal | - |
Alacrita LLP
Alacrita LLP Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Corporate Officer/Principal | - |
| ALGETA ASA | Corporate Officer/Principal | - |
Training of Brian McGuinness
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies | Health Technology |
Apex Healthcare, Inc.
Apex Healthcare, Inc. Internet Software/ServicesTechnology Services Provides web based managed care technology and administrative service solutions | Technology Services |
The University of Southampton
The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bristol
University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IP2IPO Innovations Ltd.
IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business development and technology transfer services | Commercial Services |
The Open University
The Open University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures pharmaceutical products | Commercial Services |
Algeta ASA
Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
Nxera Pharma UK Ltd.
Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Health Technology |
Crescendo Biologics Ltd.
Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the development of new medicines based on antibody fragment technology | Commercial Services |
BerGenBio ASA
BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
Alacrita LLP
Alacrita LLP Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
- Stock Market
- Insiders
- Brian McGuinness
















